Joshua Korzenik
Appearances
DateMay 7, 2023BACKGROUND: Anti-granulocyte macrophage-colony stimulating factor autoantibodies (anti-GM-CSF) have been associated with development of Crohn’s disease (CD) and complications at time of diagnosis. There are limited data on anti-GM-CSF as a prognostic biomarker in CD…Presenter
Speakers
Rhode Island Hospital/Hasbro Children's HospitalIcahn School of Medicine at Mount Sinai- DateMay 7, 2023BACKGROUND: Anti-granulocyte macrophage-colony stimulating factor autoantibodies (anti-GM-CSF) have been associated with development of Crohn’s disease (CD) and complications at time of diagnosis. There are limited data on anti-GM-CSF as a prognostic biomarker in CD…
- DateMay 18, 2024
Presenter
- DateMay 19, 2024Anti-granulocyte/macrophage-colony stimulating factor autoantibody (GM-CSF AuAB) has been identified before the onset of Crohn’s Disease (CD) and is associated with an increase in complicated disease. However, its connection to the gut microbiome, a key factor in CD progression, remains unclear…
Presenter
Speakers
Emory UniversityCincinnati Children’s Hospital Medical CenterIcahn School of Medicine at Mount Sinai - DateMay 19, 2024Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) maintains mononuclear phagocytes (MNP) and supports intestinal immune homeostasis. Anti-GM-CSF autoantibodies (aGMAbs) are found in approx. 25% of all Crohn’s disease (CD) patients…
Speakers
Icahn School of Medicine at Mount SinaiPresenter
DateMay 18, 2024CARING FOR CHILDREN AND YOUNG ADULTS WITH AUTOIMMUNE LIVER DISEASE AND IBDModerators
Mayo Foundation for Medical Education and ResearchMayo Clinic RochesterSpeakers
University of Chicago Division of the Biological Sciences
